JNBA Financial Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 865 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 892 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 756 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 712 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 677 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 637 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 598 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 588 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 614 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 639 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 714 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 701 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 568 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | +$239 | ﹤0.01% | 737 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | – | – | 730 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 544 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 511 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 491 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 481 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 463 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 503 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | +$373 | ﹤0.01% | 1388 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | – | – | 1680 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 554 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 566 |
|
|
2015
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 550 |
|
|
2015
Q3 | $1K | Buy |
+1
| New | +$1.46K | ﹤0.01% | 511 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 547 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 561 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 593 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 604 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 524 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 496 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 452 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 445 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 380 |
|
Other funds holding CSCI
VF
EDRH
FDCDDQ
JNBA Financial Advisors's CSCI Position: Q1 2022 in Review
JNBA Financial Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2022, closing a stake of 1 share.
JNBA Financial Advisors first reported a position in CSCI in Q3 2015 and held it in 24 quarters. The position peaked at $1K in Q3 2015. 23 funds tracked by Wall St. Rank hold CSCI as of Q1 2022.
- JNBA Financial Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- JNBA Financial Advisors sold 1 COSCIENS Biopharma Inc. Common Stock share in Q1 2022.
- JNBA Financial Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2015 and held it in 24 quarters.
- JNBA Financial Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $1K in Q3 2015.
- 23 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2022.
Based on JNBA Financial Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.